Business Combinations and Goodwill (Tables)

6 Months Ended

Jun. 30, 2024

Business Combination and Asset Acquisition [Abstract]

Schedule of Business Acquisitions, by Acquisition

The following table summarizes the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed related to each acquisition at the acquisition date (in thousands):

	CFC		AHMS		Others *		Net Total
Total purchase consideration:
Cash paid	$	90,998	$	63,935	$	12,500	$	167,433
Contingent consideration		8,026		—		6,161		14,187
Common stock issued		21,952		—		—		21,952
	$	120,976	$	63,935	$	18,661	$	203,572
Assets:
Cash and cash equivalents	$	15,083	$	33,950	$	3,515	$	52,548
Investment in marketable securities		—		—		30		30
Receivables		6,530		11,007		—		17,537
Other Receivables		472		—		—		472
Prepaid expenses and other current assets		—		36		11		47
Amount due from affiliates		2,902		—		—		2,902
Land, property and equipment		—		—		823		823
Intangible assets		28,200		23,800		3,900		55,900
Goodwill		85,208		31,811		11,121		128,140
Income tax receivable		—		—		1		1
Restricted cash		—		300		—		300
Total identifiable assets acquired	$	138,395	$	100,904	$	19,401	$	258,700
Liabilities:
Accounts payable and accrued expenses	$	1,641	$	7,111	$	250	$	9,002
Medical liabilities		15,754		15,849		—		31,603
Amount due from affiliates		—		5,890		54		5,944
Income taxes payable		24		1,689		—		1,713
Deferred tax liability		—		6,430		8		6,438
Noncontrolling interest		—		—		428		428
Total identified liabilities assumed	$	17,419	$	36,969	$	740	$	55,128
Total net identifiable assets acquired	$	120,976	$	63,935	$	18,661	$	203,572

* Others consist of estimated fair values of the assets acquired, net of cash acquired, related to ADSC and PCCCV.

Unaudited Pro Forma Financial Information

The pro forma financial information in the table below presents the combined results of the Company and CFC, AHMS, ADSC and PCCCV as if the acquisitions had occurred on January 1, 2023. The pro forma information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.

	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands, except per share amounts)	2024		2023		2024		2023
Total revenue	$	486,265	$	395,006	$	955,068	$	777,468
Net income attributable to Astrana Health, Inc.	$	19,171	$	18,337	$	37,641	$	38,660
Net income per share – basic	$	0.40	$	0.39	$	0.79	$	0.83
Net income per share – diluted	$	0.40	$	0.39	$	0.79	$	0.83

Schedule of Change in Carrying Value of Goodwill

The change in the carrying value of goodwill for the six months ended June 30, 2024 was as follows (in thousands):

	Amount
Balance, January 1, 2024	$	278,831
Acquisitions		128,140
Adjustments		2,610
Balance, June 30, 2024	$	409,581